Protara Therapeutics, Inc. Debt Securities, Available-for-sale, Amortized Cost
Protara Therapeutics, Inc. (TARA) had Debt Securities, Available-for-sale, Amortized Cost of $2.99 million as of 2024-03-31, per its 10-Q filed 2024-05-02.
Discontinued › Notes
us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis · last filed 2024-08-06
- 2024-03-31: Debt Securities, Available-for-sale, Amortized Cost $2.99M.
- 2023-12-31: Debt Securities, Available-for-sale, Amortized Cost $26.02M.
- 2023-09-30: Debt Securities, Available-for-sale, Amortized Cost $40.43M.
- 2023-06-30: Debt Securities, Available-for-sale, Amortized Cost $46.72M.
| Period end | Debt Securities, Available-for-sale, Amortized Cost |
|---|---|
| 2024-03-31 | $2.99M 10-Q · filed 2024-05-02 |
| 2023-12-31 | $26.02M 10-Q · filed 2024-08-06 |
| 2023-09-30 | $40.43M 10-Q · filed 2023-11-03 |
| 2023-06-30 | $46.72M 10-Q · filed 2023-08-03 |
| 2023-03-31 | $68.94M 10-Q · filed 2023-05-04 |
| 2022-12-31 | $78.82M 10-K · filed 2024-03-13 |
| 2022-09-30 | $60.71M 10-Q · filed 2022-11-03 |
| 2022-06-30 | $80.11M 10-Q · filed 2022-08-09 |
| 2022-03-31 | $93.99M 10-Q · filed 2022-05-05 |
| 2021-12-31 | $95.18M 10-K · filed 2023-03-08 |
| 2021-09-30 | $97.71M 10-Q · filed 2021-11-04 |
| 2021-06-30 | $98.31M 10-Q · filed 2021-08-05 |
| 2021-03-31 | $97.13M 10-Q · filed 2021-05-06 |
| 2018-12-31 | $2.50M 10-K · filed 2020-03-20 |
| 2018-09-30 | $7.99M 10-Q · filed 2018-11-07 |
| 2018-06-30 | $13.97M 10-Q · filed 2018-08-07 |
| 2018-03-31 | $11.47M 10-Q · filed 2018-05-09 |
| 2017-12-31 | $20.99M 10-K · filed 2019-03-13 |
| 2017-09-30 | $27.45M 10-Q · filed 2017-11-07 |
| 2017-06-30 | $13.36M 10-Q · filed 2017-08-07 |
| 2016-12-31 | $4.92M 10-K · filed 2018-03-14 |
| 2016-09-30 | $20.29M 10-Q · filed 2016-11-07 |
| 2016-06-30 | $19.48M 10-Q · filed 2016-08-08 |
| 2016-03-31 | $35.31M 10-Q · filed 2016-05-09 |
| 2015-12-31 | $25.24M 10-K · filed 2017-03-16 |
| 2015-06-30 | $57.92M 10-Q · filed 2015-08-13 |
| 2015-03-31 | $69.74M 10-Q · filed 2015-05-13 |
| 2014-12-31 | $14.76M 10-K · filed 2016-03-14 |
| 2013-12-31 | $2.36M 10-K · filed 2015-03-20 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Compass Therapeutics, Inc. (CMPX) | United States | $0.204B | -5.35 |
| Alpha Cognition Inc. (ACOG) | $0.185B | -6.77 | |
| Alector, Inc. (ALEC) | United States | $0.213B | -1.90 |
| Coherus Oncology, Inc. (CHRS) | United States | $0.182B | -1.63 |
| ANAVEX LIFE SCIENCES CORP. (AVXL) | United States | $0.218B | -18.37 |
| Protalix BioTherapeutics, Inc. (PLX) | $0.221B | 9.87 | |
| PRECISION BIOSCIENCES INC (DTIL) | United States | $0.175B | -3.95 |
| Voyager Therapeutics, Inc. (VYGR) | United States | $0.173B | -1.99 |
| Acumen Pharmaceuticals, Inc. (ABOS) | United States | $0.162B | -1.83 |
| Outlook Therapeutics, Inc. (OTLK) | United States | $0.162B | -4.90 |